PL3048165T3 - Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im - Google Patents

Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im

Info

Publication number
PL3048165T3
PL3048165T3 PL14755102T PL14755102T PL3048165T3 PL 3048165 T3 PL3048165 T3 PL 3048165T3 PL 14755102 T PL14755102 T PL 14755102T PL 14755102 T PL14755102 T PL 14755102T PL 3048165 T3 PL3048165 T3 PL 3048165T3
Authority
PL
Poland
Prior art keywords
obesity
prevention
treatment
associated diseases
bifidobacterium animalis
Prior art date
Application number
PL14755102T
Other languages
English (en)
Inventor
Patricia Martorell Guerola
Mª Empar CHENOLL CUADROS
Daniel RAMÓN VIDAL
Pepa ORTIZ SERRANO
Silvia Llopis Pla
Núria GONZALEZ MARTÍNEZ
Salvador GENOVÉS MARTÍNEZ
Beatriz Casinos Ramo
Ángela SILVA ANGULO
Amaya ALEIXANDRE
Original Assignee
Biopolis, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopolis, S.L. filed Critical Biopolis, S.L.
Publication of PL3048165T3 publication Critical patent/PL3048165T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106Addition of, or treatment with, microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60Drinks from legumes, e.g. lupine drinks
    • A23L11/65Soy drinks
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • A23L2/382Other non-alcoholic beverages fermented
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/515Animalis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL14755102T 2013-07-18 2014-07-17 Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im PL3048165T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201331088A ES2526986B1 (es) 2013-07-18 2013-07-18 Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
PCT/ES2014/070579 WO2015007941A1 (es) 2013-07-18 2014-07-17 Nueva cepa de bifidobacterium animalis subsp. lactis cect 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
EP14755102.2A EP3048165B1 (en) 2013-07-18 2014-07-17 Novel strain of bifidobacterium animalis subsp. lactis cect 8145 and use thereof for the treatment and/or prevention of excess weight and obesity and associated diseases

Publications (1)

Publication Number Publication Date
PL3048165T3 true PL3048165T3 (pl) 2018-06-29

Family

ID=51392276

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14755102T PL3048165T3 (pl) 2013-07-18 2014-07-17 Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im

Country Status (19)

Country Link
US (1) US10946051B2 (pl)
EP (1) EP3048165B1 (pl)
CN (1) CN105849248B (pl)
AU (1) AU2014291922B2 (pl)
CA (1) CA2918430C (pl)
CY (1) CY1119770T1 (pl)
DK (1) DK3048165T3 (pl)
ES (2) ES2526986B1 (pl)
HK (1) HK1226100B (pl)
HR (1) HRP20180053T1 (pl)
HU (1) HUE035501T2 (pl)
LT (1) LT3048165T (pl)
MX (1) MX367132B (pl)
NO (1) NO3048165T3 (pl)
PL (1) PL3048165T3 (pl)
PT (1) PT3048165T (pl)
RS (1) RS56826B1 (pl)
SI (1) SI3048165T1 (pl)
WO (1) WO2015007941A1 (pl)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105002130A (zh) * 2015-07-30 2015-10-28 江南大学 一种产胆盐水解酶的基因工程菌及其构建方法与应用
EP3222282A1 (en) * 2016-03-21 2017-09-27 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of psoriasis
CN105918460A (zh) * 2016-04-11 2016-09-07 西南民族大学 一种益生菌谷物酸奶及其制备方法
CA3020365A1 (en) * 2016-04-14 2017-10-19 Dupont Nutrition Biosciences Aps Bifidobacteria for reducing food, energy and/or fat intake
EP3272396A1 (en) * 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
IT201600091033A1 (it) * 2016-09-08 2018-03-08 Bioimmunizer Sagl Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
CN109223833A (zh) * 2017-07-10 2019-01-18 上海立龙生物科技有限公司 一种预防和改善肥胖的益生菌组合物
US11833178B2 (en) 2017-08-25 2023-12-05 University College Cork—National University of Ireland, Cork Bifidobacterium longum for treating obesity and weight management
CN107699517A (zh) * 2017-10-17 2018-02-16 无限极(中国)有限公司 一种青春双歧杆菌及其用途
ES2891536T3 (es) * 2017-11-27 2022-01-28 Sosnowska Turek Ewelina Cepa Bifidobacterium animalis AMT30 y composición que contiene la cepa de Bifidobacterium animalis AMT30
JP7266580B2 (ja) * 2018-03-23 2023-04-28 森永乳業株式会社 学童期以降の高血糖に起因する疾患の予防のための乳幼児用組成物
CN112236154B (zh) * 2018-05-31 2024-10-18 深圳华大生命科学研究院 一种组合物及其应用
WO2020063553A1 (zh) 2018-09-30 2020-04-02 内蒙古伊利实业集团股份有限公司 一种乳双歧杆菌bl-99及其应用
CN109182207B (zh) * 2018-10-10 2020-10-27 北京首佳利华科技有限公司 一株具有调节血糖和胆固醇水平等益生功能的嗜酸乳杆菌La-SJLH001及其应用
CN109749955B (zh) * 2018-12-29 2020-08-21 浙江工业大学 短乳杆菌zj401及其应用
CN109666615B (zh) * 2019-02-20 2021-03-19 无限极(中国)有限公司 一种益生菌组合物及其应用
US11045507B2 (en) 2019-02-21 2021-06-29 Ewelina Sosnowska-Turek Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30
CN115279380A (zh) * 2019-12-27 2022-11-01 佰欧波利斯有限公司 来自双歧杆菌的脂磷壁酸的用途
EP3851115A1 (en) * 2020-01-15 2021-07-21 Biopolis, S.L. Probiotic composition for its use as an antioxidant
KR102136522B1 (ko) * 2020-03-04 2020-07-22 주식회사 락토메이슨 안전성 및 장부착능이 우수한 모유유래 락토바실러스 루테리 lm1071 균주, 및 상기 균주 또는 이의 배양물을 포함하는 조성물
CN111849836B (zh) * 2020-08-08 2023-09-22 洪德轩 一种具有抗氧化的鼠李糖乳杆菌及其应用
CN113207960B (zh) * 2020-08-31 2023-02-28 内蒙古蒙牛乳业(集团)股份有限公司 改善肥胖的乳双歧杆菌MN-Gup发酵乳及制备方法
EP4001399A1 (en) * 2020-11-13 2022-05-25 "NEOPHARM BULGARIA" Ltd. Strain bifidobacterium animalis ssp. lactis dsm 33647 for modulating metabolism indicators
CN112618577B (zh) * 2020-12-15 2023-07-25 深圳君拓生物科技有限公司 动物双歧杆菌在提高肿瘤免疫治疗应答中的作用
CN116981468A (zh) * 2020-12-18 2023-10-31 通用医疗公司 益生菌组合物以及使用其促进儿童生长和社交功能的方法
CN112980719B (zh) * 2020-12-30 2022-11-29 上海理工大学 一株耐氧动物双歧杆菌
CN113005060B (zh) * 2021-03-15 2022-11-01 江南大学 青春双歧杆菌ccfm1173在制备功能性菌剂、食品和或药物中的应用
CN117794557A (zh) * 2021-08-19 2024-03-29 雀巢产品有限公司 后生元
EP4387639A1 (en) * 2021-08-19 2024-06-26 Société des Produits Nestlé S.A. Postbiotic
CN114200120A (zh) * 2021-12-02 2022-03-18 兰州大学 一种治疗肥胖症的药物筛选试剂盒及其使用方法
CN114028444A (zh) * 2021-12-03 2022-02-11 南京北极光生物科技有限公司 一种益生菌组合物及其在缓解抑郁症与减少脂堆积上的应用
WO2023118868A1 (en) * 2021-12-21 2023-06-29 Quadram Institute Bioscience Bifidobacterium and compositions thereof for breast cancer treatment
CN114317354B (zh) * 2021-12-30 2024-05-07 美益添生物医药(武汉)有限公司 一种动物双歧杆菌及其培养方法和其在促进骨细胞生长和成熟中的应用
CN114480229B (zh) * 2022-04-15 2022-08-09 微康益生菌(苏州)股份有限公司 一种动物双歧杆菌乳亚种菌株wkb148及其产品与应用
WO2023205762A1 (en) 2022-04-21 2023-10-26 Abbott Laboratories Methods and compositions for slowing diabetes development or reducing a risk of diabetes
CN114574407B (zh) * 2022-05-06 2022-11-01 微康益生菌(苏州)股份有限公司 动物双歧杆菌乳亚种wkb99及其在制备改善代谢综合征制品方面的应用和产品
CN114848683B (zh) * 2022-05-09 2023-10-24 上海交通大学医学院附属瑞金医院 一种长双歧杆菌在制备预防或治疗多囊卵巢所致不孕症药物中的应用
CN115181698B (zh) * 2022-06-28 2023-09-08 广东粤港澳大湾区国家纳米科技创新研究院 一种益生菌组合物及应用
CN116286551B (zh) * 2023-04-25 2023-08-11 天赋能(天津)功能食品研究发展有限公司 长双歧杆菌婴儿亚种在调节体内脂肪代谢、塑形减脂改善肥胖方面的应用
CN116622585A (zh) * 2023-06-20 2023-08-22 广东南芯医疗科技有限公司 动物双歧杆菌乳亚种bl03在制备抗氧化和抗衰老产品中的应用
CN116590205B (zh) * 2023-07-14 2023-10-03 中国农业大学 一种动物双歧杆菌亚种组合菌剂在减肥制剂制备中的应用
CN117448198A (zh) * 2023-09-13 2024-01-26 杭州微致生物科技有限公司 一种动物双歧杆菌乳亚种vb301及其应用
CN117025489B (zh) * 2023-10-09 2024-03-19 杭州微致生物科技有限公司 一种动物双歧杆菌乳亚种vb315及其应用
CN118240724B (zh) * 2024-05-30 2024-08-16 内蒙古农业大学 一株动物双歧杆菌乳亚种ProSci-246及由其制备的产品和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101257910B (zh) * 2005-09-08 2012-05-23 株式会社益力多本社 胆固醇吸收抑制剂
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
HUP0700552A2 (en) 2007-08-27 2009-03-30 Janos Dr Feher Method and composition inhibiting inflammation
WO2010146568A2 (en) * 2009-06-19 2010-12-23 Danisco A/S Bifidobacteria for treating diabetes and related conditions
CN102858993B (zh) * 2010-01-08 2015-08-05 热尔韦·达诺尼公司 筛选具有抗氧化作用的细菌的方法
JP2011172506A (ja) * 2010-02-24 2011-09-08 Glico Dairy Products Co Ltd プロバイオティクス用のビフィドバクテリウム・アニマリス・サブスピーシーズ・ラクティス菌株及びこれを用いたプロバイオティクス乳酸菌発酵食品又はその他のプロバイオティクス経口食品。
JP2014508186A (ja) * 2011-03-17 2014-04-03 プロバイオティカル・ソシエタ・ペル・アチオニ 抗酸化活性を有するプロバイオティクス細菌およびそれらの使用

Also Published As

Publication number Publication date
CN105849248A (zh) 2016-08-10
CY1119770T1 (el) 2018-06-27
LT3048165T (lt) 2018-03-12
US10946051B2 (en) 2021-03-16
HRP20180053T1 (hr) 2018-03-23
EP3048165B1 (en) 2017-10-11
US20160143963A1 (en) 2016-05-26
WO2015007941A1 (es) 2015-01-22
MX367132B (es) 2019-08-05
HUE035501T2 (en) 2018-05-02
CA2918430A1 (en) 2015-01-22
CA2918430C (en) 2023-06-06
PT3048165T (pt) 2018-02-09
CN105849248B (zh) 2020-05-05
EP3048165A1 (en) 2016-07-27
ES2526986B1 (es) 2015-11-02
ES2526986A1 (es) 2015-01-19
AU2014291922A1 (en) 2016-02-25
AU2014291922B2 (en) 2019-11-14
MX2016000743A (es) 2016-07-14
HK1226100B (zh) 2017-09-22
DK3048165T3 (en) 2018-01-22
ES2655857T3 (es) 2018-02-21
RS56826B1 (sr) 2018-04-30
SI3048165T1 (en) 2018-04-30
NO3048165T3 (pl) 2018-03-10

Similar Documents

Publication Publication Date Title
HK1226100B (zh) 雙歧桿菌乳酸亞種(bifidobacterium animalis subsp.lactis)cect 8145的新菌株及其用於治療和/或預防超重和肥胖症以及相關疾病的用途
EP2650002A4 (en) BIFIDOBACTERIUM CECT 7765 AND ITS USE IN PREVENTING AND / OR TREATING OVERWEIGHT, OBESITY AND ASSOCIATED PATHOLOGIES
IL265774B (en) Diagnosis, prevention and treatment of joint diseases
HK1232148A1 (zh) 用於減輕絕經後女性的腹痛的動物雙歧杆菌乳酸亞種
HK1217519A1 (zh) 人體接地片及利用該人體接地片的床具墊
HUE060892T2 (hu) Probiotikus baktériumtörzsek a szájüreg betegségeinek megelõzésére és kezelésére
HK1198326A1 (zh) 用於預防或治療上呼吸道感染的鼠李糖乳桿菌和動物雙歧桿菌乳亞種
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
HK1211221A1 (en) Formulations for the treatment and prevention of obesity
HK1209346A1 (en) Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases
GB2522188B (en) A lactobacillus reuteri GMNL-263 composition for controlling body weight and its use thereof
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
ZA201607245B (en) Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring
HK1209363A1 (en) Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209366A1 (en) Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases
EP3244903C0 (en) PREPARATION COMPRISING LACTOBACILLUS REUTERI AND CITRATE FOR MEDICAL USE
EP3137097C0 (en) TREATMENT AND PREVENTION OF ALZHEIMER
HUE057445T2 (hu) Bifidobacterium animals AMT30 törzs és a Bifidobacterium animalis AMT30 törzset tartalmazó készítmények
PT3137093T (pt) Tratamento e prevenção da doença de alzheimer (da)
PL3137094T3 (pl) Leczenie i profilaktyka choroby alzheimera (ad)
LT2914754T (lt) Lactobacillus delbrueckii bakterijų nauja padermė ir jos panaudojimas bičių duonelės gamybai
GB201608841D0 (en) Use of neurotoxin in the treatment of overweight, including obesity